Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- ₹11.54 billion
- Book Value:
- Revenue TTM:
- ₹1.29 billion
- Operating Margin TTM:
- Gross Profit TTM:
- ₹881.99 million
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Paushak Limited had its IPO on under the ticker symbol 532742.
The company operates in the Other sector and Other industry. Paushak Limited has a staff strength of 259 employees.
Shares of Paushak Limited opened at ₹6628.95 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹6480 - ₹6642.9, and closed at ₹6489.6.
This is a -1.6% slip from the previous day's closing price.
A total volume of 3,261 shares were traded at the close of the day’s session.
In the last one week, shares of Paushak Limited have slipped by -3.37%.
Paushak Limited's Key Ratios
Paushak Limited has a market cap of ₹11.54 billion, indicating a price to book ratio of 4.4693 and a price to sales ratio of 8.3393.
In the last 12-months Paushak Limited’s revenue was ₹1.29 billion with a gross profit of ₹881.99 million and an EBITDA of ₹417.57 million. The EBITDA ratio measures Paushak Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Paushak Limited’s operating margin was 28.69% while its return on assets stood at 8.93% with a return of equity of 14.84%.
In Q3, Paushak Limited’s quarterly earnings growth was a negative -18.3% while revenue growth was a negative 13.9%.
Paushak Limited’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at ₹104.273 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Paushak Limited’s profitability.
Paushak Limited stock is trading at a EV to sales ratio of 7.7984 and a EV to EBITDA ratio of 21.4212. Its price to sales ratio in the trailing 12-months stood at 8.3393.
Paushak Limited stock pays annual dividends of ₹6 per share, indicating a yield of 0.17% and a payout ratio of 7.11%.
Balance sheet and cash flow metrics
- Total Assets
- ₹4.15 billion
- Total Liabilities
- ₹223.16 million
- Operating Cash Flow
- Capital Expenditure
- ₹171.41 million
- Dividend Payout Ratio
Paushak Limited ended 2023 with ₹4.15 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹4.15 billion while shareholder equity stood at ₹3.54 billion.
Paushak Limited ended 2023 with ₹0 in deferred long-term liabilities, ₹223.16 million in other current liabilities, 30821000.00 in common stock, ₹3.51 billion in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹5.22 million and cash and short-term investments were ₹710.02 million. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.
Paushak Limited’s total current assets stands at ₹1.47 billion while long-term investments were ₹0 and short-term investments were ₹700.54 million. Its net receivables were ₹524.78 million compared to accounts payable of ₹0 and inventory worth ₹227.37 million.
In 2023, Paushak Limited's operating cash flow was ₹-382021000.00 while its capital expenditure stood at ₹171.41 million.
Comparatively, Paushak Limited paid ₹0.07 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Paushak Limited stock is currently trading at ₹6489.6 per share. It touched a 52-week high of ₹9674.4679 and a 52-week low of ₹9674.4679. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹6675.9 and 200-day moving average was ₹7287.12 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 7066.8% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Paushak Limited
Similar Industry Stocks (Other)
Paushak Limited develops, manufactures, and sells phosgene based specialty chemicals and intermediates in India and internationally. Its products include isocyanates, chloroformates, carbonates/carbamates, carbamoyl chlorides, and others. The company primarily serves pharma, agro, and specialty chemical companies. Paushak Limited was incorporated in 1972 and is based in Vadodara, India.